As the industry moves away from traditional models of manufacturing, having an effective technology transfer plan will be essential.
Visible Particles: Why is This Still a Pain Point?
Deborah Shnek, PhD, Drug Product Development LLC
Rapid Micro Methods: Where Are They Now? Features
Kim Sobien, BD Rx, and Rebecca Stauffer, PDA
Inconsistent Expectations Clash with Industry Best Practices for Sterile Products
Paul Larocque, Acerna Inc
USP <1116> and its Implications for Measuring Microbial Recovery Rates
Claudio Denoya, PhD, and Gilberto Dalmaso, PhD, Particle Measuring Systems
InfoGraphic: The Future of Aseptic Processing is Now!
Teaching Compliance in Financial Terms
Jennifer Magnani and Anders Vinther, PhD, Sanofi Pasteur
PDA Points to Consider on Quality Culture
PDA Quality Metrics Task Force
So Many Reg Questions, So Many Answers
Maria Guazzaroni Jacobs, PhD, Pfizer, and Susan Schniepp, Regulatory Compliance Associates
Cold Chain, Supply Chain Face Changing World
Rafik Bishara, PhD, and Erik van Asselt, PhD, Merck Sharp & Dohme